Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

1.7K
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
1.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Microbial Corrosion01:24

Microbial Corrosion

112
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
112
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observations of the Gas Phase Composition of the 2024 BioLab Industrial Plume in the Atlanta Metropolitan Area.

Environmental science & technology letters·2026
Same author

Screening for torticollis and plagiocephaly: The role of the pediatrician.

Medicine·2025
Same author

Importance of arachidonic acid in long-chain polyunsaturated fatty acid-supplemented infant formula.

The American journal of clinical nutrition·2005
See all related articles

Related Experiment Video

Updated: May 7, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.9K

Developing regulatory strategy for microbicides.

Ronald Nardi1, Linda Arterburn, Lisa Carlton

  • 1International Partnership for Microbicides, 8401 Colesville Road, Suite 200, Silver Spring, MD, 20910, USA, rnardi@ipmglobal.org.

Current Topics in Microbiology and Immunology
|October 16, 2013
PubMed
Summary

Developing effective HIV prevention microbicides is crucial for global health. Approvals require navigating complex regulatory landscapes in both developed and emerging markets, demanding flexible strategies for diverse requirements.

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

Related Experiment Videos

Last Updated: May 7, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
18:46

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

13.9K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Drug Development

Background:

  • Human Immunodeficiency Virus (HIV) infection remains a significant global health challenge, driving research into prevention strategies.
  • Antiretroviral therapies have advanced HIV treatment, but prevention methods like microbicides are essential for controlling transmission.
  • Despite extensive research, no microbicide products for HIV prevention have received global approval to date.

Purpose of the Study:

  • To highlight the critical need for approved microbicide products in HIV prevention.
  • To emphasize the importance of adapting development strategies to evolving disease landscapes and regulatory environments.
  • To outline the challenges and requirements for gaining regulatory approval for microbicides in diverse global markets.

Main Methods:

  • Review of current HIV prevention research and therapeutic targets.
  • Analysis of global regulatory pathways for pharmaceutical product approval.
  • Examination of challenges in emerging markets for product registration.

Main Results:

  • Microbicide products represent a viable, globally applicable HIV prevention strategy.
  • Successful development and approval necessitate addressing the dynamic nature of the HIV epidemic.
  • Navigating distinct regulatory requirements in developed and emerging markets is key for product accessibility.

Conclusions:

  • The development of HIV prevention microbicides requires a strategic approach to regulatory affairs.
  • Flexibility in meeting local requirements is essential for product approval, particularly in emerging markets with unclear pathways.
  • Leveraging existing and adapting to new regulatory frameworks will facilitate the global rollout of much-needed HIV prevention tools.